Considerations regarding the tumor-suppressor role of naringenin as a novel agent for the treatment of oral squamous cell carcinoma.
作者信息
Li Chen-Xi, Gong Zhong-Cheng, Tan Xiao-Rong
机构信息
School/Hospital of Stomatology, The First Affiliated Hospital of Xinjiang Medical University, Xinjiang Medical University, Stomatological Research Institute of Xinjiang Uygur Autonomous Region, Urumqi, 830054, China.
Hubei Province Key Laboratory of Oral and Maxillofacial Development and Regeneration, Wuhan, 430022, China.
出版信息
Cancer Immunol Immunother. 2023 Sep;72(9):3133-3134. doi: 10.1007/s00262-023-03452-0. Epub 2023 May 6.
Abstract
摘要
相似文献
1
Considerations regarding the tumor-suppressor role of naringenin as a novel agent for the treatment of oral squamous cell carcinoma.关于柚皮素作为治疗口腔鳞状细胞癌的新型药物的肿瘤抑制作用的考量。
Cancer Immunol Immunother. 2023 Sep;72(9):3133-3134. doi: 10.1007/s00262-023-03452-0. Epub 2023 May 6.
2
Marine bioactive compounds as potential therapeutic inhibitor for oral squamous cell carcinoma (OSCC).海洋生物活性化合物作为口腔鳞状细胞癌（OSCC）的潜在治疗抑制剂
Oral Oncol. 2022 Aug;131:105971. doi: 10.1016/j.oraloncology.2022.105971. Epub 2022 Jun 15.
3
MicroRNA-138 and its targets: A therapeutic molecule for oral squamous cell carcinoma.微小RNA-138及其靶点：一种用于口腔鳞状细胞癌的治疗分子。
Oral Oncol. 2022 Jul;130:105925. doi: 10.1016/j.oraloncology.2022.105925. Epub 2022 May 21.
4
Engineered exoASO-STAT6: a potent monotherapy for oral squamous cell carcinoma.工程化外泌体反义寡核苷酸-信号转导和转录激活因子6：口腔鳞状细胞癌的有效单一疗法
Future Oncol. 2022 Aug;18(25):2767-2769. doi: 10.2217/fon-2022-0496. Epub 2022 Jun 29.
5
Chronotherapeutics in the management of oral squamous cell carcinoma - A futuristic novel treatment strategy.口腔鳞状细胞癌管理中的时辰治疗学——一种未来主义的新型治疗策略。
Indian J Cancer. 2023 Oct 1;60(4):595-596. doi: 10.4103/ijc.ijc_19_23. Epub 2024 Jan 4.
6
Naringenin induces endoplasmic reticulum stress-mediated cell apoptosis and autophagy in human oral squamous cell carcinoma cells.柚皮素诱导人口腔鳞状细胞癌细胞内质网应激介导的细胞凋亡和自噬。
J Food Biochem. 2022 Nov;46(11):e14221. doi: 10.1111/jfbc.14221. Epub 2022 May 21.
7
Squamous cell carcinomas of the tongue and oral cavity as secondary malignancies: what factors are implicated?舌和口腔鳞状细胞癌作为继发性恶性肿瘤：涉及哪些因素？
Oncologist. 2013;18(3):245-7. doi: 10.1634/theoncologist.2013-0021. Epub 2013 Mar 13.
8
Novel therapeutic inhibitors for oral squamous cell cancer (OSCC) from seaweeds.来自海藻的新型口腔鳞状细胞癌（OSCC）治疗抑制剂。
Eur J Surg Oncol. 2023 May;49(5):1048-1049. doi: 10.1016/j.ejso.2023.01.013. Epub 2023 Jan 18.
9
Novel HSP90 inhibitor NVP-AUY922 enhances the anti-tumor effect of temsirolimus against oral squamous cell carcinoma.新型 HSP90 抑制剂 NVP-AUY922 增强了替西罗莫司对口腔鳞状细胞癌的抗肿瘤作用。
Curr Cancer Drug Targets. 2013 Mar;13(3):289-99. doi: 10.2174/1568009611313030007.
10
Research Progress of Metformin in the Treatment of Oral Squamous Cell Carcinoma.二甲双胍治疗口腔鳞状细胞癌的研究进展。
Endocrinology. 2023 Sep 23;164(11). doi: 10.1210/endocr/bqad139.
引用本文的文献
1
Effects of macrophages in OSCC progression.巨噬细胞在口腔鳞状细胞癌进展中的作用。
Front Immunol. 2025 Jan 14;15:1517886. doi: 10.3389/fimmu.2024.1517886. eCollection 2024.
2
Association of DOK3 and infiltrated tumor-associated macrophages with risk for the prognosis of Porphyromonas gingivalis-infected oral cancer: a 12-year data analysis of 200 patients from a tertiary teaching hospital, Urumqi, China.牙龈卟啉单胞菌感染的口腔癌预后风险与DOK3及浸润性肿瘤相关巨噬细胞的关联：来自中国乌鲁木齐一家三级教学医院200例患者的12年数据分析
BMC Cancer. 2024 Apr 26;24(1):534. doi: 10.1186/s12885-024-12300-y.
3
Naringenin-induced Oral Cancer Cell Apoptosis ROS-mediated Bid and Bcl-xl Signaling Pathway.柚皮素诱导口腔癌细胞凋亡的 ROS 介导的 Bid 和 Bcl-xl 信号通路。
Curr Cancer Drug Targets. 2024;24(6):668-679. doi: 10.2174/0115680096267430231023091521.
本文引用的文献
1
Naringenin potentiates anti-tumor immunity against oral cancer by inducing lymph node CD169-positive macrophage activation and cytotoxic T cell infiltration.柚皮素通过诱导淋巴结 CD169 阳性巨噬细胞活化和细胞毒性 T 细胞浸润增强口腔癌的抗肿瘤免疫。
Cancer Immunol Immunother. 2022 Sep;71(9):2127-2139. doi: 10.1007/s00262-022-03149-w. Epub 2022 Jan 19.
2
Exosomal and intracellular miR-320b promotes lymphatic metastasis in esophageal squamous cell carcinoma.外泌体和细胞内的miR-320b促进食管鳞状细胞癌的淋巴转移。
Mol Ther Oncolytics. 2021 Sep 25;23:163-180. doi: 10.1016/j.omto.2021.09.003. eCollection 2021 Dec 17.
3
Metastatic and sentinel lymph node mapping using intravenously delivered Panitumumab-IRDye800CW.使用静脉注射的帕尼单抗-IRDye800CW进行转移性和前哨淋巴结定位
Theranostics. 2021 May 24;11(15):7188-7198. doi: 10.7150/thno.55389. eCollection 2021.
4
Cervical squamous cell carcinoma-secreted exosomal miR-221-3p promotes lymphangiogenesis and lymphatic metastasis by targeting VASH1.宫颈鳞状细胞癌分泌的外泌体 miR-221-3p 通过靶向 VASH1 促进淋巴管生成和淋巴转移。
Oncogene. 2019 Feb;38(8):1256-1268. doi: 10.1038/s41388-018-0511-x. Epub 2018 Sep 25.
5
Possible functions of CD169-positive sinus macrophages in lymph nodes in anti-tumor immune responses.淋巴结中CD169阳性窦巨噬细胞在抗肿瘤免疫反应中的可能功能。
Cancer Sci. 2017 Mar;108(3):290-295. doi: 10.1111/cas.13137. Epub 2017 Mar 7.
Zotero 插件